Table 2 Univariate analyses concerning disease location.
| Variable | Group A (n=72) | Group B (n=26) | p value |
|---|---|---|---|
| Age, years | 73.4±7.3 | 72.0±7.4 | 0.398 |
| Male sex, % | 79.2 | 84.6 | 0.547 |
| ABI | 0.54±0.21 | 0.64±0.20 | 0.046* |
| BMI, kg/m2 | 22.0±3.4 | 23.4±2.9 | 0.072 |
| Smoking, % | 75.0 | 69.2 | 0.568 |
| Comorbidities | |||
| Hypertension, % | 72.2 | 76.9 | 0.642 |
| DM, % | 50.0 | 26.9 | 0.046* |
| CVD, % | 34.7 | 23.1 | 0.274 |
| IHD, % | 36.1 | 38.5 | 0.831 |
| HD, % | 16.7 | 3.8 | 0.099 |
| Serum ω-3 fatty acids | |||
| EPA, µg/mL | 65.1±38.6 | 85.3±46.6 | 0.038* |
| DHA, µg/mL | 130.1±47.6 | 164.4±61.8 | 0.008* |
| AA, µg/mL | 173.2±46.1 | 176.8±42.7 | 0.733 |
| DHLA, µg/mL | 35.8±14.1 | 36.5±13.7 | 0.832 |
| Serum lipids | |||
| TC, mg/dL | 175.0±37.6 | 180.2±33.2 | 0.531 |
| TG, mg/dL | 140.8±84.4 | 182.0±86.1 | 0.048* |
| HDL, mg/dL | 46.9±13.6 | 44.9±15.2 | 0.523 |
| LDL, mg/dL | 99.7±35.8 | 100.0±27.5 | 0.968 |
* p value significant. Abbreviations as in Table 1.